Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 17.85
-2.40 (-11.85%)
Aug 21, 2026, 3:04 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 10.62 billion as of August 21, 2026. Its market cap has decreased by -4.55% in one year.
Market Cap
10.62B
Enterprise Value
7.87B
Revenue
1.20B
Ranking
n/a
PE Ratio
56.65
Stock Price
17.85
ChartMarket Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 10.62B, a decrease of -62.23%. That is a compound annual growth rate of -19.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 10.62B | -4.19% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 12.41B |
| Chengdu Olymvax Biopharmaceuticals | 11.93B |
| Tibet Cheezheng Tibetan Medicine | 11.72B |
| Staidson (Beijing) BioPharmaceuticals | 11.50B |
| Inner Mongolia Furui Medical Science | 11.35B |
| Chengzhi | 11.18B |
| Pacific Shuanglin Bio-pharmacy | 10.49B |
| Chongqing Genrix Biopharmaceutical | 9.82B |